BiomX closes private placement, issues 3,300 Series Y Preferred shares; appoints director

BiomX Inc.

Closed private placement of 3,300 Series Y Convertible Preferred shares and warrants on January 13, 2026.
Board appointed Reuven Yeganeh as Class 1 director, effective at closing; board size increased to nine.
Yeganeh is CEO of Continual Ltd. and independent under NYSE American rules; since 2024 also director of Nukkleus Inc.
Company entered into standard indemnification agreement with Yeganeh.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.7

BiomX Inc.: Filed Certificate of Designations for Series Y Convertible Preferred Stock, creating a new series of preferred stock with specific rights and preferences (effective 2026-01-13).

Change: charter amendment
Effective: 2026-01-13

Exact text from the filing

On January 13, 2026, the Company filed a Certificate of Designations of Series Y Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State of the State of Delaware

View on SEC.gov

Browse all governance changes →

BiomX Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-004348

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.